Silo Pharma, Inc.
NASDAQ: SILO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eric Weisblum
- Employees
- 3
- Headquarters
- Sarasota, United States
- IPO year
- 2021
- Market cap
- $5.6M
- Website
- https://silopharma.com
Loading SILO…
Loading profile data…Frequently asked questions about SILO
What does Silo Pharma, Inc. (SILO) do?
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and...
Where does SILO trade?
Silo Pharma, Inc. (SILO) trades on the NASDAQ Capital Market.
What sector is SILO in?
Silo Pharma, Inc. (SILO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Silo Pharma, Inc.?
Eric Weisblum is the chief executive officer of Silo Pharma, Inc. (SILO).
Where is Silo Pharma, Inc. headquartered?
Silo Pharma, Inc. is headquartered in United States.
Does SILO pay a dividend?
Silo Pharma, Inc. (SILO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SILO go public?
Silo Pharma, Inc. (SILO) completed its initial public offering in 2021.